Edition:
United Kingdom

China Pioneer Pharma Holdings Ltd (1345.HK)

1345.HK on Hong Kong Stock

2.64HKD
26 Apr 2018
Change (% chg)

HK$-0.02 (-0.75%)
Prev Close
HK$2.66
Open
HK$2.64
Day's High
HK$2.68
Day's Low
HK$2.62
Volume
213,000
Avg. Vol
1,778,292
52-wk High
HK$3.22
52-wk Low
HK$2.11

Latest Key Developments (Source: Significant Developments)

China Pioneer Pharma Holdings Posts FY Net Profit Of RMB280.6 Mln
Wednesday, 21 Mar 2018 

March 21 (Reuters) - China Pioneer Pharma Holdings Ltd <1345.HK>::FY ‍REVENUE INCREASED BY 20.3% TO RMB2,153.9 MILLION​.‍FY NET PROFIT INCREASED BY 17.6% TO RMB280.6 MILLION​.  Full Article

China Pioneer Pharma Enters Agreement For Sale Of Ophthalmic Pharmaceutical Products
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - China Pioneer Pharma Holdings Ltd <1345.HK>::CO ‍ENTERED AGREEMENT WITH ALCON AND AFFILIATE BEIJING NOVARTIS PHARMACEUTICAL CO FOR SALE OF OPHTHALMIC PHARMACEUTICAL PRODUCTS.PARTIES AGREE THAT ALCON & BEIJING NOVARTIS TO CONTINUE TO SUPPLY MINIMUM VALUE OF ALCON PRODUCTS TO CO FOR YEAR ENDING DEC 2018.‍ TOTAL VALUE OF ALCON PRODUCTS WHICH GROUP MAY SELL IN 2018 WILL BE NO LESS THAN RMB617 MILLION (NET OF TAX)​.  Full Article

China Pioneer Pharma Holdings says HY net profit of group RMB142.7 mln
Wednesday, 23 Aug 2017 

Aug 23 (Reuters) - China Pioneer Pharma Holdings Ltd <1345.HK>:Net profit of group for six months ended 30 June 2017 was RMB142.7 million, which represents a 42.7 pct increase.Interim dividend of RMB6.4 cents per share.Revenue of group for six months ended 30 June 2017 was RMB1,028.2 million, up 27.6 percent.  Full Article

China Pioneer Pharma Holdings entered into distribution agreement
Friday, 30 Jun 2017 

June 30 (Reuters) - China Pioneer Pharma Holdings Ltd <1345.HK>::Company entered into a distribution agreement with Ortho Development Corporation.Agreement in relation to exclusive distribution rights of BKS products in China.Company is granted exclusive distribution rights to Ortho Development's balanced knee system products in People's Republic Of China​.  Full Article

China Pioneer Pharma Holdings updates on possible sale of Pioneer Pharma's stake in co
Thursday, 8 Jun 2017 

June 8 (Reuters) - China Pioneer Pharma Holdings Ltd <1345.HK>:Gives update on talks between Pioneer Pharma (Bvi) Co & third parties on possible sale of Pioneer Pharma's stake in co.Says talks between parties regarding possible transaction have not come to any conclusion.  Full Article

China Pioneer Pharma redesignates Zhu Mengjun to CEO; appoints Xue Yi as CFO
Wednesday, 28 Dec 2016 

China Pioneer Pharma Holdings Ltd <1345.HK> : Zhu Mengjun has been redesignated from position of chief financial officer to chief executive officer . Xue Yi has been appointed as chief financial officer of company .Wang Yinping resigned as ceo ; redesignated from position of executive director to non-executive director.  Full Article

BRIEF-China Pioneer Pharma Holdings Posts FY Net Profit Of RMB280.6 Mln

* ‍FY NET PROFIT INCREASED BY 17.6% TO RMB280.6 MILLION​ Source text for Eikon: Further company coverage: